Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nucana Plc (NCNA)
NASDAQ:NCNA
Holding NCNA?
Track your performance easily
NCNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.26 - $19.40
Previous Close$1.28
Volume100.98K
Average Volume (3M)1.39M
Market Cap
$2.99M
Enterprise Value-$14.85M
Total Cash (Recent Filing)$17.23M
Total Debt (Recent Filing)$396.00K
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Mar 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-16.50
Shares Outstanding2,250,000
10 Day Avg. Volume148,592
30 Day Avg. Volume1,387,183
Standard Deviation0.33
R-Squared0.03
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.19
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.88
Forecast
1Y Price Target
$22.50Price Target Upside1671.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Nucana News
PremiumCompany Announcements
NuCana’s NUC-3373 Shows Promise in Cancer Treatment
PremiumCompany Announcements
NuCana plc Enhances Offering to $5.4 Million
PremiumCompany Announcements
NuCana Secures US Patent for Promising Cancer Drug
Ownership Overview
11.00%
Insiders
0.03% Mutual Funds
8.22% Other Institutional Investors
80.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
NCNA FAQ
What was Nucana Plc’s price range in the past 12 months?
Nucana Plc lowest stock price was $1.26 and its highest was $19.40 in the past 12 months.
What is Nucana Plc’s market cap?
Currently, no data Available
When is Nucana Plc’s upcoming earnings report date?
Nucana Plc’s upcoming earnings report date is Mar 06, 2025 which is in 104 days.
How were Nucana Plc’s earnings last quarter?
Currently, no data Available
Is Nucana Plc overvalued?
According to Wall Street analysts Nucana Plc’s price is currently Undervalued.
Does Nucana Plc pay dividends?
Nucana Plc does not currently pay dividends.
What is Nucana Plc’s EPS estimate?
Nucana Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nucana Plc have?
Nucana Plc has 2,266,430 shares outstanding.
What happened to Nucana Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nucana Plc?
Currently, no hedge funds are holding shares in NCNA
---
Nucana Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.50 (1671.65% Upside)
$22.50 (1671.65% Upside)
Blogger Sentiment
Bullish
NCNA Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.68%
12-Months-Change
Fundamentals
Return on Equity
-179.05%
Trailing 12-Months
Asset Growth
-51.63%
Trailing 12-Months
Company Description
Nucana Plc
NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology is consists of acelarin, NUC-3373, and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
---
NCNA Stock 12 Month Forecast
Average Price Target
$22.50
▲(1671.65% Upside)
Technical Analysis
Adaptimmune Therapeutics
―
Verastem
―
TRACON Pharmaceuticals
―
Cellectar Biosciences
―
Best Analysts Covering NCNA
1 Year
1 Year Success Rate
2/17 ratings generated profit
1 Year Average Return
-52.16%
reiterated a buy rating 2 months ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -52.16% per trade.
---